Exagen
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell Exagen and other ETFs, options, and stocks.About XGN
Exagen, Inc. is a commercial-stage diagnostics company, which engages in transforming the care continuum for patients suffering from debilitating and chronic autoimmune diseases by enabling timely differential diagnosis and optimizing therapeutic intervention. It operates under the Avise brand.
CEOJohn Aballi
CEOJohn Aballi
Employees209
Employees209
HeadquartersVista, California
HeadquartersVista, California
Founded2002
Founded2002
Employees209
Employees209
XGN Key Statistics
Market cap145.72M
Market cap145.72M
Price-Earnings ratio-6.95
Price-Earnings ratio-6.95
Dividend yield—
Dividend yield—
Average volume236.40K
Average volume236.40K
High today$6.61
High today$6.61
Low today$6.22
Low today$6.22
Open price$6.49
Open price$6.49
Volume268.89K
Volume268.89K
52 Week high$12.23
52 Week high$12.23
52 Week low$2.67
52 Week low$2.67
Stock Snapshot
The current Exagen(XGN) stock price is $6.24, with a market capitalization of 145.72M. The stock trades at a price-to-earnings (P/E) ratio of -6.95.
On 2025-12-21, Exagen(XGN) stock traded between a low of $6.22 and a high of $6.61. Shares are currently priced at $6.24, which is +0.4% above the low and -5.5% below the high.
The Exagen(XGN)'s current trading volume is 268.89K, compared to an average daily volume of 236.4K.
In the last year, Exagen(XGN) shares hit a 52-week high of $12.23 and a 52-week low of $2.67.
In the last year, Exagen(XGN) shares hit a 52-week high of $12.23 and a 52-week low of $2.67.
Analyst ratings
100%
of 8 ratingsBuy
100%
Hold
0%
Sell
0%
People also own
Based on the portfolios of people who own XGN. This list is generated using Robinhood data, and it’s not a recommendation.